Skip to content

The Impact of Fish Oil Supplementation on Muscle Growth in Older Men

The impact of n-3 PUFA supplementation on daily muscle protein synthesis rates in older men

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26123
Enrollment
13
Registered
2016-05-18
Start date
2016-06-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Loss of skeletal muscle mass and strength with aging, also termed sarcopenia

Interventions

The experimental trial consists of two 5-d phases separated by 4 weeks of supplementation. Muscle protein synthesis will be determined during the last 2 d of each 5-d phase. For each phase, dietary in

Sponsors

McMaster University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Male 2) Age 65-80 y 3) BMI between 18.5 and 30 kg/m2 4) Generally healthy as assessed by medical questionnaire 5) Willing and able to provide informed consent

Exclusion criteria

Exclusion criteria: 1) Medical, orthopedic, or psychiatric concern that, in the opinion of the investigators, would compromise the ability to comply with the study requirements 2) History of cancer within the last 5 years, except basal cell carcinoma, non-squamous skin carcinoma, prostate cancer or carcinoma in situ with no significant progression over the past 2 years 3) Significant orthopedic, cardiovascular, pulmonary, renal, liver, infectious disease, immune disorder, or metabolic/endocrine disorders or other disease that would affect protein metabolism 4) Current illnesses which could interfere with the study (e.g. prolonged severe diarrhea or regurgitation) 5) Subject participated in a study of an investigational product less than 60 days or 5 half-lives of the investigational product, whichever is longer, before enrollment in this study 6) Excessive alcohol consumption (>21 units/week) 7) Smoking 8) Prior gastrointestinal bypass surgery 9) History of bleeding diathesis, platelet or coagulation disorders, or antiplatelet/anticoagulation therapy 10) Use of corticosteroids, testosterone replacement therapy (ingestion, injection, or transdermal), or any anabolic steroid 11) Participation in an exercise program

Design outcomes

Primary

MeasureTime frame
Daily muscle protein synthesis rates assessed using D2O before and after 4 weeks of fish oil supplementation

Secondary

MeasureTime frame
1) Muscle and blood lipid composition before, during, and after fish oil supplementation 2) Plasma markers of inflammatory state before, during, and after fish oil supplementation 3) Insulin sensitivity as assessed by oral glucose tolerance test following the ingestion of 75 g glucose before and after 4 weeks of fish oil supplementation

Contacts

Public ContactStefan Gorissen

Department of Kinesiology - McMaster University

E-mail: gorisses@mcmaster.ca+1 905 730 5894

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)